Current status:
Cancelled Post Market
Current status date:
2018-11-28
DIN:
02248807
Electronic product monograph is not available
Route(s) of administration:
Intramuscular
,
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
List of active ingredient(s)
Active ingredient(s) |
Strength |
FLUNIXIN (FLUNIXIN MEGLUMINE)
|
50 MG / ML
|